Pharmaceutical Executive-01-01-2009

"Test and treat" strategies aren't just for new-to-market drugs anymore.

Every industry has a life cycle, and pharma's has just entered its competitive stage. Here's how to prepare.

How hopeful are execs about the future of their own companies and the industry in general?

The graphic novel emerges as a versatile, effective medical education and marketing tool

The headlines are about layoffs, but some segments of pharma are still hiring. Pay, meanwhile, tightens.

It's just the way life works: You're always crossing the bridge before you get to it-or after it's gone

With no formal fair market value guidelines imposed by the government, how "fair" is it for pharma to play by the rules?

Will more resourches and new leadership fix FDA, or is a major overhaul in order?

We know what you're thinking: new president, rotten economy, patent cliff. Do you feel Evel? Well, do you?